{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:48:34Z","timestamp":1790455714663,"version":"4.1.0"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Opioid-related overdose accounts for almost 80\u202f000 deaths annually across the US. People who use drugs leaving jails are at particularly high risk for opioid-related overdose and may benefit from take-home naloxone (THN) distribution.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate the population impact of THN distribution at jail release to reverse opioid-related overdose among people with opioid use disorders.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This study developed the agent-based Justice-Community Circulation Model (JCCM) to model a synthetic population of individuals with and without a history of opioid use. Epidemiological data from 2014 to 2020 for Cook County, Illinois, were used to identify parameters pertinent to the synthetic population. Twenty-seven experimental scenarios were examined to capture diverse strategies of THN distribution and use. Sensitivity analysis was performed to identify critical mediating and moderating variables associated with population impact and a proxy metric for cost-effectiveness (ie, the direct costs of THN kits distributed per death averted). Data were analyzed between February 2022 and March 2024.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Modeled interventions included 3 THN distribution channels: community facilities and practitioners; jail, at release; and social network or peers of persons released from jail.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the percentage of opioid-related overdose deaths averted with THN in the modeled population relative to a baseline scenario with no intervention.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Take-home naloxone distribution at jail release had the highest median (IQR) percentage of averted deaths at 11.70% (6.57%-15.75%). The probability of bystander presence at an opioid overdose showed the greatest proportional contribution (27.15%) to the variance in deaths averted in persons released from jail. The estimated costs of distributed THN kits were less than $15\u202f000 per averted death in all 27 scenarios.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study found that THN distribution at jail release is an economical and feasible approach to substantially reducing opioid-related overdose mortality. Training and preparation of proficient and willing bystanders are central factors in reaching the full potential of this intervention.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.48732","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:25:59Z","timestamp":1733829959000},"page":"e2448732","source":"Crossref","is-referenced-by-count":12,"title":["Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution"],"prefix":"10.1001","volume":"7","author":[{"given":"Eric","family":"Tatara","sequence":"first","affiliation":[{"name":"Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, Illinois"},{"name":"Consortium for Advanced Science and Engineering, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ozik","sequence":"additional","affiliation":[{"name":"Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, Illinois"},{"name":"Consortium for Advanced Science and Engineering, The University of Chicago, Chicago, Illinois"},{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"},{"name":"Northwestern-Argonne Institute for Science and Engineering, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Pollack","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"},{"name":"Crown Family School of Social Work, Policy, and Practice, The University of Chicago, Chicago, Illinois"},{"name":"Urban Health Lab, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago, Chicago, Illinois"},{"name":"Crown Family School of Social Work, Policy, and Practice, The University of Chicago, Chicago, Illinois"},{"name":"Department of Medicine, The University of Chicago, Chicago, Illinois"},{"name":"Chicago Center for HIV Elimination, Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Grossman School of Medicine, New York"},{"name":"Center for Drug Use and HIV Research, NYU School of Global Public Health, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina T.","family":"Harawa","sequence":"additional","affiliation":[{"name":"Fielding School of Public Health, UCLA (University of California, Los Angeles)"},{"name":"David Geffen School of Medicine at UCLA"},{"name":"College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basmattee","family":"Boodram","sequence":"additional","affiliation":[{"name":"Division of Community Health Sciences, School of Public Health, The University of Illinois, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Salisbury-Afshar","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin at Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hotton","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Chicago, Chicago, Illinois"},{"name":"Chicago Center for HIV Elimination, Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Ouellet","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Mackesy-Amiti","sequence":"additional","affiliation":[{"name":"Division of Community Health Sciences, School of Public Health, The University of Illinois, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholson","family":"Collier","sequence":"additional","affiliation":[{"name":"Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, Illinois"},{"name":"Consortium for Advanced Science and Engineering, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Macal","sequence":"additional","affiliation":[{"name":"Decision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, Illinois"},{"name":"Consortium for Advanced Science and Engineering, The University of Chicago, Chicago, Illinois"},{"name":"Northwestern-Argonne Institute for Science and Engineering, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"issue":"4","key":"zoi241367r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.7036","article-title":"Estimated costs and outcomes associated with use and nonuse of medications for opioid use disorder during incarceration and at release in Massachusetts.","volume":"6","author":"Chatterjee","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi241367r4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.","volume":"159","author":"Binswanger","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi241367r5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1078345819882771","article-title":"Overdose education and naloxone distribution in the San Francisco County Jail.","volume":"25","author":"Wenger","year":"2019","journal-title":"J Correct Health Care"},{"key":"zoi241367r6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.drugalcdep.2018.04.034","article-title":"Beyond the walls: risk factors for overdose mortality following release from the Philadelphia Department of Prisons.","volume":"189","author":"Pizzicato","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"zoi241367r7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000-2015.","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"Am J Public Health"},{"issue":"1","key":"zoi241367r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi241367r9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? systematic review utilizing application of the Bradford Hill criteria.","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"zoi241367r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109478","article-title":"Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin.","volume":"236","author":"Coffin","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi241367r11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13011-021-00346-1","article-title":"A scoping review of factors that influence opioid overdose prevention for justice-involved populations.","volume":"16","author":"Grella","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"zoi241367r12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.drugpo.2017.05.015","article-title":"A mapping review of take-home naloxone for people released from correctional settings.","volume":"46","author":"Horton","year":"2017","journal-title":"Int J Drug Policy"},{"key":"zoi241367r13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.addbeh.2018.12.017","article-title":"Documenting need for naloxone distribution in the Los Angeles County Jail system.","volume":"92","author":"Davidson","year":"2019","journal-title":"Addict Behav"},{"key":"zoi241367r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102841","article-title":"Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: a microsimulation modeling study.","volume":"91","author":"Macmadu","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi241367r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3469658","article-title":"Dynamic computational models and simulations of the opioid crisis: a comprehensive survey.","volume":"3","author":"Shojaati","year":"2022","journal-title":"ACM Trans Comput Healthc"},{"key":"zoi241367r17","doi-asserted-by":"publisher","DOI":"10.1177\/26334895211010664","article-title":"Agent-based modeling for implementation research: an application to tobacco smoking cessation for persons with serious mental illness.","volume":"2","author":"Huang","year":"2021","journal-title":"Implement Res Pract"},{"issue":"5","key":"zoi241367r18","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S2468-2667(18)30044-6","article-title":"Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.","volume":"3","author":"Irvine","year":"2018","journal-title":"Lancet Public Health"},{"issue":"9","key":"zoi241367r19","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.14664","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"key":"zoi241367r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.011","article-title":"The role of mathematical modelling in aiding public health policy decision-making: a case study of the BC opioid overdose emergency.","volume":"88","author":"Irvine","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"3","key":"zoi241367r21","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","article-title":"Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.","volume":"7","author":"Irvine","year":"2022","journal-title":"Lancet Public Health"},{"key":"zoi241367r22","first-page":"989","article-title":"Application of distributed agent-based modeling to investigate opioid use outcomes in justice involved populations.","volume":"2021","author":"Tatara","year":"2021","journal-title":"IEEE Int Symp Parallel Distrib Process Workshops Phd Forum"},{"issue":"11","key":"zoi241367r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.41174","article-title":"Comparing projected fatal overdose outcomes and costs of strategies to expand community-based distribution of naloxone in Rhode Island.","volume":"5","author":"Zang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi241367r24","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","article-title":"Modeling health benefits and harms of public policy responses to the US opioid epidemic.","volume":"108","author":"Pitt","year":"2018","journal-title":"Am J Public Health"},{"key":"zoi241367r25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","article-title":"Effects of naloxone distribution to likely bystanders: results of an agent-based model.","volume":"55","author":"Keane","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"9","key":"zoi241367r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137993","article-title":"Agent-based model forecasts aging of the population of people who inject drugs in metropolitan Chicago and changing prevalence of hepatitis C infections.","volume":"10","author":"Gutfraind","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"zoi241367r27","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jval.2023.04.004","article-title":"Developing criteria for health economic quality evaluation tool.","volume":"26","author":"Kim","year":"2023","journal-title":"Value Health"},{"key":"zoi241367r29","first-page":"1008","article-title":"Multi-objective model exploration of hepatitis C elimination in an agent-based model of people who inject drugs.","volume":"2019","author":"Tatara","year":"2019","journal-title":"Proc Winter Simul Conf"},{"issue":"1","key":"zoi241367r30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13012-021-01105-3","article-title":"The FRAME-IS: a framework for documenting modifications to implementation strategies in healthcare.","volume":"16","author":"Miller","year":"2021","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241367r31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/QAI.0b013e318050d260","article-title":"Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study.","volume":"45","author":"Huo","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"zoi241367r32","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3109\/10826081003682875","article-title":"Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago.","volume":"45","author":"Broz","year":"2010","journal-title":"Subst Use Misuse"},{"issue":"6","key":"zoi241367r33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064789","article-title":"Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.","volume":"8","author":"Tempalski","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"zoi241367r41","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/08897077.2021.1986877","article-title":"Costs of opioid overdose education and naloxone distribution in New York City.","volume":"43","author":"Behrends","year":"2022","journal-title":"Subst Abus"},{"key":"zoi241367r42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cpc.2009.09.018","article-title":"Variance based sensitivity analysis of model output. Design and estimator for the total sensitivity index.","volume":"181","author":"Saltelli","year":"2010","journal-title":"Comput Phys Commun"},{"issue":"1","key":"zoi241367r43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40352-018-0073-6","article-title":"Criminal justice measures for economic data harmonization in substance use disorder research.","volume":"6","author":"McCollister","year":"2018","journal-title":"Health Justice"},{"key":"zoi241367r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114293","article-title":"Bridging institutional logics: implementing naloxone distribution for people exiting jail in three California counties.","volume":"285","author":"Showalter","year":"2021","journal-title":"Soc Sci Med"},{"key":"zoi241367r47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2018.07.003","article-title":"Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade.","volume":"59","author":"Tobin","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi241367r48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13012-021-01172-6","article-title":"Cost data in implementation science: categories and approaches to costing.","volume":"17","author":"Gold","year":"2022","journal-title":"Implement Sci"},{"issue":"1","key":"zoi241367r50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12954-022-00604-w","article-title":"Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.","volume":"19","author":"Bennett","year":"2022","journal-title":"Harm Reduct J"},{"issue":"12","key":"zoi241367r51","doi-asserted-by":"publisher","DOI":"10.2196\/22411","article-title":"Reasons people who use opioids do not accept or carry no-cost naloxone: qualitative interview study.","volume":"4","author":"Bennett","year":"2020","journal-title":"JMIR Form Res"},{"issue":"17","key":"zoi241367r52","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2023.4800","article-title":"Population-level health effects of involuntary displacement of people experiencing unsheltered homelessness who inject drugs in US cities.","volume":"329","author":"Barocas","year":"2023","journal-title":"JAMA"},{"key":"zoi241367r53","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103200","article-title":"\u201cI wanted to close the chapter completely \u2026 and I feel like that [carrying naloxone] would keep it open a little bit\u201d: refusal to carry naloxone among newly-abstinent opioid users and 12-step identity.","volume":"94","author":"Bowles","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi241367r54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12954-022-00627-3","article-title":"Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.","volume":"19","author":"Abdelal","year":"2022","journal-title":"Harm Reduct J"},{"issue":"10","key":"zoi241367r55","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/add.15458","article-title":"Heroin use cannot be measured adequately with a general population survey.","volume":"116","author":"Reuter","year":"2021","journal-title":"Addiction"},{"issue":"9","key":"zoi241367r56","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.34704","article-title":"Factors associated with the availability of medications for opioid use disorder in US jails.","volume":"7","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi241367r14","volume-title":"Just and Ethical Study Designs in the Opioid Epidemic","author":"Pollack","year":"2023"},{"key":"zoi241367r28","author":"Collier","year":"2020"},{"key":"zoi241367r1","unstructured":"Ahmad? F, Rossen? L, Sutton? P. Provisional drug overdose death counts. 2021. Accessed January 2024. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi241367r2","unstructured":"NCHS: a blog of the National Center for Health Statistics: provisional data shows U.S. drug overdose deaths top 100,000 in 2022. Centers for Disease Control and Prevention. May 23, 2023. Accessed July 1, 2023. https:\/\/blogs.cdc.gov\/nchs\/2023\/05\/18\/7365\/#:~:text=The%2082%2C998%20predicted%20opioid%2Dinvolved,82%2C310%20in%20the%20previous%20year?"},{"key":"zoi241367r34","unstructured":"OpenData archive. Cook County Sheriff\u2019s Office. Accessed March 25, 2021. https:\/\/cookcountysheriffil.gov\/data\/"},{"key":"zoi241367r35","unstructured":"Olson? D, Taheri? S. Population dynamics and the characteristics of inmates in the Cook County Jail. 2012. Accessed January 2024. https:\/\/ecommons.luc.edu\/criminaljustice_facpubs\/"},{"key":"zoi241367r36","unstructured":"Jall population YOY. Cook County: STAR performance management. Cook County Sheriff\u2019s Office. Accessed October 28, 2021. https:\/\/performance-archive.cookcountyil.gov\/Public-Safety\/Jail-Population-YOY\/t3ix-ahaa"},{"key":"zoi241367r37","unstructured":"SAFE-T Act resources. Illinois State Association of Counties. Accessed September 30, 2024. https:\/\/www.isacoil.org\/safe-t-act-resources\/"},{"key":"zoi241367r38","unstructured":"Arrestee Drug Abuse Monitoring? II. (ADAM II) annual report: 2014. Office of National Drug Control Policy. Accessed March 2021. https:\/\/obamawhitehouse.archives.gov\/ondcp\/arrestee-drug-abuse-monitoring-program"},{"key":"zoi241367r39","unstructured":"Medical examiner case archive: 2021. Cook County Government Open Data. Accessed January 2023. https:\/\/datacatalog.cookcountyil.gov\/Public-Safety\/Medical-Examiner-Case-Archive\/cjeq-bs86"},{"key":"zoi241367r40","unstructured":"Illinois opioid data dashboard: 2021. Illinois Dept of Public Health. Accessed January 2024. https:\/\/idph.illinois.gov\/OpioidDataDashboard\/"},{"key":"zoi241367r44","unstructured":"Michener? P. Implementation of Medications for Opioid Use Disorder in Jail Settings and the Post-Release Environment. Dissertation. UMass Chan Medical School; 2024. doi:10.13028\/19fh-kn88"},{"key":"zoi241367r46","unstructured":"Never use alone website. Accessed January 2024. https:\/\/neverusealone.com"},{"key":"zoi241367r49","unstructured":"The brave app: overdose detection for people who use drugs. Brave. Accessed January 2024. https:\/\/www.brave.coop\/overdose-detection-app"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2827627\/tatara_2024_oi_241367_1732741434.30773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:26:06Z","timestamp":1733829966000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2827627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.48732","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}